Synbio International, Inc. (SYIN)
OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
At close: Oct 8, 2026
Synbio International Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
238.04K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2007 | 98.56K | -16.39K | -14.26% |
| Dec 31, 2006 | 114.95K | 925.00 | 0.81% |
| Dec 31, 2005 | 114.02K | - | - |
| Dec 31, 2004 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Synbio International News
- 8 days ago - Synbio (OTC: SYIN) Outlines a Two-Engine Healthcare Growth Strategy Combining Nutraceuticals and AI-Powered Mental Health Screening - TheNewswire
- 4 weeks ago - Synbio International Signs Exclusive Licensing Agreement for Proprietary Nutraceutical Products, Accelerating Path to Revenue - TheNewswire
- 1 month ago - Synbio International Commences Revenue-Generating Operations With Launch of Healing Force™ Nutraceutical Division - TheNewswire
- 6 months ago - Synbio International Secures DWAC and DRS Eligibility - TheNewswire
- 8 months ago - Synbio Signs Agreement for a Proof-of-Concept Clinical Trial to Evaluate a Unique AI-Based Facial Analysis Screening Software for Mental Health Disorders - TheNewswire
- 1 year ago - Synbio International Inc. Expands Board and Strengthens Leadership with Appointment of Chief Financial Officer Ms. Desiree Cain, CPA, MBA - GlobeNewsWire